Sunnova Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Stock Information for Alterity Therapeutics Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Alterity Therapeutics Limited

Sunnova Announces Strategic Action to Facilitate Value-Maximizing Sale Process
Sunnova Announces Appointment of Two Independent Directors
Sunnova Receives Continued Listing Notice from NYSE
Sunnova Announces Appointment of Robyn Liska as Interim Chief Financial Officer and Provides Financial Strategy Update
Sunnova Adopts Tax Asset Preservation Plan Designed to Protect the Availability of its Net Operating Losses
Tortoise Capital Announces Index Updates for First Quarter 2025
Sunnova Names Paul Mathews as President and Chief Executive Officer
Sunnova Reports Fourth Quarter and Full Year 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.